Current Status and Prospect of Stent Placement for May-Thurner Syndrome

Abstract

Stent implantation has been proven to be safe and has become the first-line intervention for May-Thurner syndrome (MTS), with satisfactory mid-term patency rates and clinical outcomes. Recent research has demonstrated that catheter-directed thrombolysis is the preferred strategy when MTS is combined with deep vein thrombosis after self-expanding stent placement. However, the stent used for the venous system was developed based on the experience obtained in the treatment of arterial disease. Consequently, relatively common corresponding complications may come along later, which include stent displacement, deformation, and obstruction. Different measures such as adopting a stent with a larger diameter, improving stent flexibility, and increasing stent strength have been employed in order to prevent these complications. The ideal venous stent is presently being evaluated and will be introduced in detail in this review.

Keywords

May-Thurner syndrome / deep vein thrombosis / post-thrombotic syndromes / stent / stent placement

References

[1] EliahouR, SosnaJ, BloomAI. Between a rock and a hard place: Clinical and imaging features of vascular compression syndromes. Radiographics, 2012, 32(1): E33-E49

[2] BirnJ, VedanthamS. May-Thurner syndrome and other obstructive iliac vein lesions: Meaning, myth, and mystery. Vascular Medicine, 2015, 20(1): 74-83

[3] Al-OmariMH, AljarrahQM, FataftahJ, et al.. Endovascular management of May-Thurner syndrome in a patient with left-sided superior vena cava: A case report. Am J Case Rep, 2019, 20: 713-718

[4] HageAN, SrinivasaRN, AbramowitzSD, et al.. Endovascular iliocaval reconstruction for the treatment of iliocaval thrombosis: From imaging to intervention. Vasc Med, 2018, 23(3): 267-275

[5] ParkJY, AhnJH, JeonYS, et al.. Iliac vein stenting as a durable option for residual stenosis after catheter-directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to may-thurner syndrome. Phlebology, 2014, 29: 461-470

[6] MingZB, LiWD, YuanRF, et al.. Effectiveness of catheter directed thrombolysis and stent implantation on iliofemoral vein thrombosis caused by iliac vein compression. J Thromb Thrombolysis, 2017, 44(2): 254-260

[7] KnuttinenM, NaiduS, OkluR, et al.. May-Thurner: Diagnosis and endovascular management. Cardiovasc Diagn Ther, 2017, 7(Suppl 3): S159-S164

[8] HagerES, YuoT, TaharaR, et al.. Outcomes of endovascular intervention for May-Thurner syndrome. J Vasc Surg Venous Lymphat Disord, 2013, 1(3): 270-275

[9] MurphyE H, JohnsB, VarneyE, et al.. Endovascular management of chronic total occlusions of the inferior vena cava and iliac veins. J Vasc Surg Venous Lymphat Disord, 2017, 5(1): 47-59

[10] ChaitJ, AlsheekhA, AurshinaA, et al.. Effect of venous access site on postintervention stent thrombosis for nonthrombotic iliac vein stenting. J Vasc Surg Venous Lymphat Disord, 2020, 8(1): 84-88

[11] DasariM, AvgerinosE, RajuS, et al.. Outcomes of iliac vein stents after pregnancy. J Vasc Surg Venous Lymphat Disord, 2017, 5(3): 353-357

[12] Shamimi-Noori SM, Clark TWI. Venous stents: Current status and future directions. Tech Vasc Interv Radiol, 2018,(2):113–116

[13] KwakHS, HanYM, LeeYS, et al.. Stents in common iliac vein obstruction with acute ipsilateral deep venous thrombosis: Early and late results. J Vasc Interv Radi, 2005, 16(6): 815-822

[14] RazaviMK, JaffMR, MillerLE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction. Circ Cardiovasc Interv, 2015, 8(10): e002772

[15] CarrollS, MollS. Inferior Vena Cava Filters, May-Thurner syndrome, and vein stents. Circulation, 2016, 133(6): e383-e387

[16] IbrahimW, Al SafranZ, HasanH, et al.. Endovascular management of may-thurner syndrome. Ann Vasc Dis, 2012, 5(2): 217-221

[17] ButrosSR, LiuR, OliveiraGR, et al.. Venous compression syndromes: Clinical features, imaging findings and management. Brit J Radio, 2013, 86(1030): 20130284

[18] RajuS. Treatment of iliac-caval outflow obstruction. Semin Vasc Surg, 2015, 28(1): 47-53

[19] WhiteJM, ComerotaAJ. Venous compression syndromes. Vasc Endovasc Surg, 2017, 51(3): 155-168

[20] SudheendraD, VedanthamS. Catheter-directed therapy options for iliofemoral venous thrombosis. Surg Clin N Am, 2018, 98(2): 255-265

[21] RajuS, MontminyML, ThomassonJD, et al.. A comparison between intravascular ultrasound and venography in identifying key parameters essential for iliac vein stenting. J Vasc Surg Venous Lymphat Disord, 2019, 7(6): 801-807

[22] StuckAK, ReichT, EngelbergerRP, et al.. Endovascular treatment of post-thrombotic and non-thrombotic iliofemoral venous outflow obstructions with self-expanding nitinol stents. Vasa, 2018, 47(4): 319-325

[23] FunatsuA, AnzaiH, KomiyamaK, et al.. Stent implantation for May-Thurner syndrome with acute deep venous thrombosis: Acute and long-term results from the ATOMIC (AcTive stenting for May-Thurner Iliac Compression syndrome) registry. Cardiovasc Interv Ther, 2019, 34: 131

[24] IbrahimW, Al SafranZ, HasanH, et al.. Endovascular management of may-thurner syndrome. Ann Vasc Dis, 2012, 5(2): 217-221

[25] DesaiKR, LawsJL, SalemR, et al.. Defining prolonged dwell time: When are advanced inferior vena cava filter retrieval techniques necessary? An analysis in 762 procedures. Circ Cardiovasc Interv, 2017, 10(6): e003957

[26] KasirajanK, GrayB, OurielK. Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol, 2001, 12(2): 179-185

[27] IyerS, AngleJF, UflackerA, et al.. Venous compression syndromes: a review. Curr Treat Options Cardiovasc Med, 2017, 19(6): 45

[28] Abdul-HaqqR, NovakZ, PearceBJ, et al.. Routine extended follow-up surveillance of iliac vein stents for iliocaval venous obstruction may not be warranted. J Vasc Surg Venous Lymphat Disord, 2017, 5(4): 500-505

[29] AttaranRR, OzdemirD, LinI, et al.. Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting: Factors associated with stent occlusion. J Vasc Surg Venous Lymphat Disord, 2019, 7(4): 527-534

[30] ZuckerEJ, GanguliS, GhoshhajraBB, et al.. Imaging of venous compression syndromes. Cardiovasc Diagn Ther, 2016, 6(6): 519-532

[31] KnippBS, FergusonE, WilliamsDM, et al.. Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndrome. J Vasc Surg, 2007, 46(4): 743-749

[32] ChoH, KimJW, HongYS, et al.. Stent Compression in iliac vein compression syndrome associated with acute ilio-femoral deep vein Thrombosis. Korean J Radiol, 2015, 16(4): 723-728

[33] LichtenbergMKW, de GraafR, StahlhoffWF, et al.. Venovo venous stent in the treatment of non-thrombotic or post-thrombotic iliac vein lesions — short-term results from the Arnsberg venous registry. Vasa, 2019, 48(2): 175-180

[34] ChickJFB, SrinivasaRN, CooperKJ, et al.. Endovascular Iliocaval reconstruction for chronic iliocaval thrombosis: the data, where we are, and how it is done. Tech Vasc Interv Radiol, 2018, 21(2): 92-104

[35] BondarevS, KellerEJ, HanT, et al.. Predictors of disease recurrence after venoplasty and stent placement for May-Thurner syndrome. J Vasc Interv Radiol, 2019, 30(10): 1549-1554

[36] J PadrnosL, GarciaD. May-Thurner syndrome and thrombosis: a systematic review of antithrombotic use after endovascular stent placement. Res Pract Thromb Haemost, 2018, 3(1): 70-78

[37] LichtenbergM, DeRG, ErbelC. Standards for recanalisation of chronic venous outflow obstructions. Vasa, 2018, 47(4): 259-266

[38] XuJS, LiuYJ, ZhouWM. Mid- and long-term efficacy of endovascular-based procedures for Cockett syndrome. Sci Rep, 2018, 8(1): 12145

[39] YinSW, GuoLW, BianL, et al.. Evaluation of percutaneous mechanical thrombectomy via the AngioJet system combined with catheter-directed thrombolysis for the treatment of symptomatic lower extremity deep venous thrombosis. Ann Vasc Surg, 2020, 65: 66-71

[40] HageAN, SrinivasaRN, AbramowitzSD, et al.. Endovascular iliocaval stent reconstruction for iliocaval thrombosis: a multi-institutional international practice pattern survey. Ann Vasc Surg, 2018, 49: 64-74

[41] MoudgillN, HagerE, GonsalvesC, et al.. May-Thurner syndrome: Case report and review of the literature involving modern endovascular therapy. Vascular, 2009, 17(6): 330-335

[42] LiuF, LüP, JinB. Catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis. Ann Vasc Surg, 2011, 25(5): 707-715

[43] Bu’LockFA, TometzkiAJ, KitchinerDJ, et al.. Balloon expandable stents for systemic venous pathway stenosis late after Mustard’s operation. Heart, 1998, 79(3): 225-229

[44] TianC, LiuB, LiuJ, et al.. Comparison of self-expandable stents and balloon-mounted stents in the treatment of symptomatic intracranial vertebral artery atherosclerotic stenosis. Am J Transl Res, 2021, 13(3): 1607-1616

[45] WawrzyńskaM, ArkowskiJ, WłodarczakA, et al.Functionalised Cardiovascular Stents. 3-Development of Drug-Eluting Stents (DES), 2018, Sawston, Woodhead Publishing: 45-56

[46] HulsbergPC, McloneyE, PartoviS, et al.. Minimally invasive treatments for venous compression syndromes. Cardiovasc Diagn Ther, 2016, 6(6): 582-592

[47] SchweinA, GeorgY, LejayA, et al.. Endovascular treatment for venous diseases: Where are the venous stents?. Methodist Debakey Cardiovasc J, 2018, 14(3): 208-213

[48] RajuS. Best management options for chronic iliac vein stenosis and occlusion. J Vasc Surg, 2013, 57(4): 1163-1169

[49] XueGH, HuangXZ, YeM, et al.. Catheter-directed thrombolysis and stenting in the treatment of iliac vein compression syndrome with acute iliofemoral deep vein thrombosis: Outcome and follow-up. Ann Vasc Surg, 2014, 28(4): 957-963

[50] MandoR, Sigua-ArceP, SpencerL, et al.. Slippery stents: a case report and review of the literature describing patients with May-Thurner syndrome that experienced stent migration. Case Rep Vasc Med, 2019, 2019: 7606727

[51] ElmahdyS, ShultsCC, Alhaj MoustafaM. An unusual cause of acute heart failure: a case report of iliocaval venous stent migration. J Investig Med High Impact Case Rep, 2018, 6: 2324709618799118

[52] GordonBM, FishbeinMC, LeviDS. Polytetrafluo-roethylene-covered stents in the venous and arterial system: angiographic and pathologic findings in a swine model. Cardiovasc Pathol, 2008, 17(4): 206-211

[53] Hsieh MJ, Huang YC, Yeh JK, et al. Predictors of long-term outcomes after drug-eluting balloon angioplasty for bare-metal stent restenosis. Heart Lung Circ, 2017, S1443950617304857

[54] JayarajA, BuckW, KnightA, et al.. Impact of degree of stenosis in May-Thurner syndrome on iliac vein stenting. J Vasc Surg Venous Lymphat Disord, 2019, 7(2): 195-202

[55] NeglénP, RajuS. In-stent recurrent stenosis in stents placed in the lower extremity venous outflow tract. J Vasc Surg, 2004, 39(1): 181-187

[56] RadaidehQ, PatelNM, ShammasNW. Iliac vein compression: Epidemiology, diagnosis and treatment. Vasc Health Risk Manag, 2019, 15: 115-122

[57] KhairySA, NevesRJ, HartungO, et al.. Factors associated with contralateral deep venous thrombosis after iliocaval venous stenting. J Vasc Surg, 2018, 67(1): 358-359

[58] ErbenY, BjarnasonH, OladottirGL, et al.. Endovascular recanalization for nonmalignant obstruction of the inferior vena cava. J Vasc Surg Venous Lymphat Disord, 2018, 6(2): 173-182

[59] JayarajA, PowellT, RajuS. Utility of the 50% stenosis criterion for patients undergoing stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord, 2021, 9(6): 1408-1415

[60] RajuS, WardM J, KirkO. A modification of iliac vein stent technique. Ann Vasc Surg, 2014, 28(6): 1485-1492

[61] Bu’LockFA, TometzkiAJ, KitchinerDJ, et al.. Balloon expandable stents for systemic venous pathway stenosis late after Mustard’s operation. Heart, 1998, 79(3): 225-229

[62] WardCJ, MullinsCE, NihillMR, et al.. Use of intravascular stents in systemic venous and systemic venous baffle obstructions. Short-term follow-up results. Circulation, 1995, 91(12): 2948-2954

[63] MurphyEH, JohnsB, VarneyE, et al.. Deep venous thrombosis associated with caval extension of iliac stents. J Vasc Surg Venous Lymphat Disord, 2017, 5(1): 8-17

[64] van VuurenTM, de WolfMA, WittensCH. Relevance of flexibility versus radial force in rigid versus more flexible venous stents?. Phlebology, 2019, 34(7): 459-465

[65] BaquetM, NefH, GoriT, et al.. Restenosis patterns after bioresorbable vascular scaffold implantation: Angiographic substudy of the GHOST-EU registry. Catheter Cardiovasc Interv, 2018, 92(2): 276-282

[66] ShenD, QiH, LinW, et al.. PDLLA-Zn-nitrided Fe bioresorbable scaffold with 53-µm-thick metallic struts and tunable multistage biodegradation function. Sci Adv, 2021, 7(23): eabf0614

[67] NiL, ChenH, LuoZ, et al.. Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis. J Cardiothorac Surg, 2020, 15(1): 26

[68] AbdullahK, Bou DarghamB, SteinbrecherM, et al.. Drug-eluting stents for treatment of peripheral artery disease. Am J Cardiovascular Drugs, 2018, 18(3): 175-180

[69] LichtenbergM, BreuckmannF, StahlhoffWF, et al.. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions — short-term safety, patency, and clinical outcomes. Vasa, 2018, 47(6): 475-481